Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 12—December 2024
Research Letter

Replication-Competent Oropouche Virus in Semen of Traveler Returning to Italy from Cuba, 2024

Concetta Castilletti1, Ralph Huits1Comments to Author , Rebeca Passarelli Mantovani, Silvia Accordini, Francesca Alladio, and Federico Gobbi
Author affiliations: IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, Italy (C. Castilletti, R. Huits, R. Passarelli Mantovani, S. Accordini, F. Alladio, F. Gobbi); University of Brescia, Brescia, Italy (F. Gobbi)

Main Article

Figure 1

Clinical events and laboratory findings associated with OROV infection in a 42-year-old man from Italy who visited Cuba during July 19–29, 2024. Shown is clinical timeline of patient’s OROV infection, with key days indicating the onset of symptoms and the results of both endpoint and real-time RT-PCR tests of whole blood, serum, urine, and semen samples. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CHIKV, chikungunya virus; Ct, cycle threshold; DENV, dengue virus; eGFR, estimated glomerular filtration rate; NT, not tested; neg, negative; OROV, Oropouche virus; pos, positive; RT-PCR, reverse transcription PCR; ZIKV, Zika virus.

Figure 1. Clinical events and laboratory findings associated with OROV infection in a 42-year-old man from Italy who visited Cuba during July 19–29, 2024. Shown is clinical timeline of patient’s OROV infection, with key days indicating the onset of symptoms and the results of both endpoint and real-time RT-PCR tests of whole blood, serum, urine, and semen samples. ALT, alanine aminotransferase; AST, aspartate aminotransferase; CHIKV, chikungunya virus; Ct, cycle threshold; DENV, dengue virus; eGFR, estimated glomerular filtration rate; NT, not tested; neg, negative; OROV, Oropouche virus; pos, positive; RT-PCR, reverse transcription PCR; ZIKV, Zika virus.

Main Article

1These authors contributed equally to this article.

Page created: October 07, 2024
Page updated: October 07, 2024
Page reviewed: October 07, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external